Good question. There has been clinical testing done and the WW market is massive and BIIB will be impacted by any competition. So, it should be on the radar. Seems an obvious choice to me.
IMO, the work being done here by combining ERP technology, AI tool suites and CNS Cellular Homeostasis is priceless. I can only imagine what the team members and other informed bodies who have insight into the science must be thinking. This is not a fantasy.That, is the beauty that A lot of very smart hard working people are about to engage in a process of learning which will quickly demonstrate that the terms untreatable CNS disease will have to be redefined.
All of those here who are familiar w/the dynamics of technology and business tool development will know it is never an easy ride. We do have all the right people, saying the right stuff with the best science. There is a pony in here somewhere. Carry on.
News 
Market Data 
Discover 
